HOME >> MEDICINE >> NEWS
Possible Mechanism For Estrogen Memory Enhancement Found

University of Southern California neuroscientists have found a chemical mechanism that explains how estrogen enhances the process believed responsible for memory.

"Previous studies have suggested that the hormone estrogen delays the onset of Alzheimer's disease, and several million post-menopausal women are taking estrogen supplements for that reason," says USC neurophysiologist Richard F. Thompson, Ph.D. "Our research reveals a chemical mechanism that could explain how the delay in onset occurs."

Dr. Thompson and his colleagues measured the excitability and long-term potentiation between neurons from the brain of a rat, both before and after exposing slices of the brain's hippocampus to estrogen. The researchers looked specifically at the hormone's influence on a neurotransmitter called glutamate and two of its receptors, NMDA and AMPA. Neurotransmitters are chemicals that mediate the transmission of electrical impulses across the synapses between neurons.

"The estrogen activated both receptors within minutes -- causing a lasting increase in neuronal activity," Thompson reports. "Estrogen also enhanced the process of long-term potentiation. Activating the NMDA receptor apparently initiates long-term potentiation, and the AMPA receptors maintain it."

Since its discovery more than two decades ago, long-term potentiation has been intensively studied in hundreds of research laboratories around the world. The phenomenon is a long-lasting increase in neuronal responses in the hippocampus, a major structure in the forebrain of all mammals. It is thought to be a mechanism of memory shortage in the brain.

Thompson believes that learning more about the mechanism of long-term potentiation could lead to highly refined treatments for Alzheimer's disease. Researchers are studying compounds that are similar or related to estrogen in the hope of finding a drug precisely targeted for the treatment of disease while avoiding unwanted side-effects.

USC neur
'"/>

Contact: Bob Calverley
calverle@usc.edu
213-740-4750
University of Southern California
17-Mar-1999


Page: 1 2

Related medicine news :

1. Mayo Clinic researchers restore lost immunity -- Possible breakthrough for AIDS
2. Possible brain cancer-air pollution link to be studied
3. Possible new cancer therapy shrinks tumors in melanoma patients, Science authors report
4. Possible outpatient relief for millions of older men: MD researcher develops improved technology to shrink enlarged prostate glands without surgery
5. Possible link between heart attack and helicobacter pylori infection
6. UI Researchers Identify Possible Reason For Rare, Accelerated Aging Condition
7. New Procedure Makes A Successful Transplant Possible
8. Future Chlamydia Screening Should Take Account Of Possible Disadvantages For Women
9. UF Researchers Cite Possible Link Between Autism, Schizophrenia And Diet
10. More Evidence Of Possible Adverse Effects From New Hormone Use In Women With Heart Disease
11. Commercial Scale Cultivation Of Pharmaceutical-Producing Tobacco Possible, Virginia Tech Scientists Find

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2017)... ... June 20, 2017 , ... Caduceus ... is pleased to announce a new online course entitled Personal & Community ... insights and evidence-based strategies for achieving optimal well-being and teaches students how to ...
(Date:6/20/2017)... ... 20, 2017 , ... Fresenius Vascular Care, a national network of outpatient vascular ... manage a wide range of vascular conditions, has today announced its new name, Azura ... represented by more than 40 local brands, a phased rollout of the new brand ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... ... report contending that the introduction of school choice can promote economic development in ... charter school that has, according to the report, contributed to the economic development ...
(Date:6/20/2017)... ... June 20, 2017 , ... AMC Health , ... and success in the clinical trials market. Similar to its approach in demonstrating positive ... the clinical trials marketplace by proving the value of eVisits to support virtual studies. ...
(Date:6/20/2017)... ... June 20, 2017 , ... Leading dental clinicians, Drs. Ashlyn ... with the VATECH PaX-i and Anatomage systems. With advanced digital images and modeling capabilities, ... place dental implants precisely and restore oral health for those who are missing ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... Inc., (Nasdaq: NVAX ) today announced that data ... RSV F protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) ... the journal Vaccine (the data contained ... The Company previously announced top line results from ... F Vaccine with the goal of protecting infants from RSV ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
(Date:5/30/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will present ... Conference on Tuesday, June 13, 2017, in Rancho ... president and chief executive officer, is scheduled to present at ... can be accessed at http://ir.hill-rom.com/events.cfm . A recorded replay ... event through September 13, 2017. ...
Breaking Medicine Technology:
Cached News: